166 related articles for article (PubMed ID: 23725568)
1. Emerging therapies for rheumatoid arthritis.
Jacques P; Van den Bosch F
Expert Opin Emerg Drugs; 2013 Jun; 18(2):231-44. PubMed ID: 23725568
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapeutics for rheumatoid arthritis.
Bingham CO
Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
[TBL] [Abstract][Full Text] [Related]
3. JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy.
Vaddi K; Luchi M
Expert Opin Investig Drugs; 2012 Jul; 21(7):961-73. PubMed ID: 22612502
[TBL] [Abstract][Full Text] [Related]
4. Kinase inhibitors: the next generation of therapies in the treatment of rheumatoid arthritis.
MacFarlane LA; Todd DJ
Int J Rheum Dis; 2014 May; 17(4):359-68. PubMed ID: 24460872
[TBL] [Abstract][Full Text] [Related]
5. New and future agents in the treatment of rheumatoid arthritis.
van Vollenhoven RF
Discov Med; 2010 Apr; 9(47):319-27. PubMed ID: 20423676
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis: an overview of new and emerging therapies.
Doan T; Massarotti E
J Clin Pharmacol; 2005 Jul; 45(7):751-62. PubMed ID: 15951465
[TBL] [Abstract][Full Text] [Related]
7. Small molecular compounds in development for rheumatoid arthritis.
van Vollenhoven RF
Curr Opin Rheumatol; 2013 May; 25(3):391-7. PubMed ID: 23492738
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Janus kinases in rheumatoid arthritis: focus on tofacitinib.
Yamaoka K; Tanaka Y
Expert Opin Pharmacother; 2014 Jan; 15(1):103-13. PubMed ID: 24188100
[TBL] [Abstract][Full Text] [Related]
9. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
10. Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis.
Iwata S; Tanaka Y
Expert Rev Clin Immunol; 2016 Oct; 12(10):1047-57. PubMed ID: 27253519
[TBL] [Abstract][Full Text] [Related]
11. Relative efficacies: antimalarials to abatacept - the choice is ours.
Russell AS
J Rheumatol Suppl; 2009 Jun; 82():17-24. PubMed ID: 19509326
[TBL] [Abstract][Full Text] [Related]
12. Emerging biologic drugs for the treatment of rheumatoid arthritis.
Puppo F; Murdaca G; Ghio M; Indiveri F
Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
[TBL] [Abstract][Full Text] [Related]
13. Small molecular therapies for rheumatoid arthritis: where do we stand?
Cohen S
Expert Opin Investig Drugs; 2012 Jan; 21(1):23-31. PubMed ID: 22070089
[TBL] [Abstract][Full Text] [Related]
14. Selective JAK inhibitors in development for rheumatoid arthritis.
Norman P
Expert Opin Investig Drugs; 2014 Aug; 23(8):1067-77. PubMed ID: 24818516
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib for treatment of rheumatoid arthritis.
Rakieh C; Conaghan PG
Adv Ther; 2013 Aug; 30(8):713-26. PubMed ID: 23943546
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis.
Korhonen R; Moilanen E
Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):13-21. PubMed ID: 19686542
[TBL] [Abstract][Full Text] [Related]
17. Are biological targets the final goal for rheumatoid arthritis therapy?
Sharma P; Pathak K
Expert Opin Biol Ther; 2012 Dec; 12(12):1611-22. PubMed ID: 22954024
[TBL] [Abstract][Full Text] [Related]
18. Biologics in early rheumatoid arthritis.
de Vries-Bouwstra JK; Dijkmans BA; Breedveld FC
Rheum Dis Clin North Am; 2005 Nov; 31(4):745-62. PubMed ID: 16287595
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
20. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
